ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.260,97
0,52%
S&P 500
5.221,42
-0,02%
US Dollar vs BRL
5,1509
0,09%
Bitcoin
63.088,92
2,67%
Brent Oil
83,255
1,06%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) Notícias

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:STX
DataHoraFonteTítuloCódigoCompanhia
10/05/202411:30RNS Regulatory NewsShield Therapeutics PLC Audited results for the year ended 31 Dec 2023LSE:STXShield Therapeutics Plc
30/04/202415:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:STXShield Therapeutics Plc
30/04/202403:00RNS Regulatory NewsShield Therapeutics PLC Business Update for Q1 2024LSE:STXShield Therapeutics Plc
16/04/202403:00RNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
21/02/202409:36Alliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
21/02/202404:00RNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
09/01/202408:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
09/01/202404:00UK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
07/12/202312:31Alliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
07/12/202304:00UK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
27/11/202314:24UK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
20/10/202307:45RNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
12/10/202307:14Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
12/10/202303:00UK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
03/10/202313:14Alliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
03/10/202311:00UK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
03/10/202310:29Alliance NewsAlliance NewsShield Therapeutics completes USD20 million SWK financingLSE:STXShield Therapeutics Plc
03/10/202303:00UK RegulatoryShield Therapeutics PLC Block listing Interim ReturnLSE:STXShield Therapeutics Plc
03/10/202303:00UK RegulatoryShield Therapeutics PLC Completion of SWK FinancingLSE:STXShield Therapeutics Plc
28/09/202310:54Alliance NewsAlliance NewsUPDATE: Shield Therapeutics completes GBP5 million share placingLSE:STXShield Therapeutics Plc
28/09/202308:50UK RegulatoryShield Therapeutics PLC Successful completion of US$6.1m Equity FundraiseLSE:STXShield Therapeutics Plc
28/09/202307:30Alliance NewsAlliance NewsShield Therapeutics raises funds for US sales push as loss narrowsLSE:STXShield Therapeutics Plc
28/09/202303:02UK RegulatoryShield Therapeutics PLC REX Retail OfferLSE:STXShield Therapeutics Plc
28/09/202303:01UK RegulatoryShield Therapeutics PLC $20m secured debt facility &proposed equity raiseLSE:STXShield Therapeutics Plc
28/09/202303:00UK RegulatoryShield Therapeutics PLC Interim results update and business updateLSE:STXShield Therapeutics Plc
06/09/202316:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsLSE:STXShield Therapeutics Plc
06/09/202303:00UK RegulatoryShield Therapeutics PLC Notice of Results and Change in reporting currencyLSE:STXShield Therapeutics Plc
06/08/202313:07Alliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:STXShield Therapeutics Plc
06/08/202310:17Alliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:STXShield Therapeutics Plc
24/07/202310:27UK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
 Apresentando as notícias mais relevantes sobre:LSE:STX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
HAGA3
HAGA ON
BOV
COGN3
COGNA ON
BOV
AZEV4
AZEVEDO PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
LUPA3
LUPATECH ON
BOV
AMAR3
LOJAS MARISA ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
ETER3
ETERNIT ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
HBOR3
HELBOR ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados